Cited by 64RNA Research and SplicingRNA and protein synthesis mechanismsHIV Research and Treatment

Regulation of polyadenylation in human immunodeficiency virus (HIV): contributions of promoter proximity and upstream sequences

Open access
Cherrington, J., Ganem, D.·1992·The EMBO Journal

Abstract

Retroviruses synthesize a terminally redundant genomic RNA that contains canonical polyadenylation signals at both ends. Production of this RNA requires that the 5' copy of these signals be ignored, while the 3' copy must be utilized. Two models have been presented for how this occurs in the human immunodeficiency virus, HIV: (i) the core HIV poly(A) signals (AAUAAA and a downstream GU-rich element) might be inefficient and require supplementation by activating sequences found only at the 3' end of the RNA; or (ii) cap site proximity might actively suppress polyadenylation at the 5' site. We have examined both possibilities in HIV-infected cells and in cells transfected with a variety of model constructs. We find that infected cells harbor few or no detectable products of 5' polyadenylation; however, the core HIV processing signals can mediate processing fairly efficiently (65%) when positioned at the 3' end of heterologous transcripts. While this efficiency can be further increased to greater than 95% by inclusion of upstream sequences from the viral U3 region, the absence of these U3 signals is insufficient by itself to account for 5' signal bypass. By contrast, the efficiency of these core elements is greatly suppressed when they are positioned within approximately 450 nucleotides of the cap site. This distance-related suppression can be modestly diminished by insertion of U3 sequences between the cap site and HIV poly(A) signal. We suggest that the primary determinant of 5' poly(A) site bypass is cap site proximity; the absence of U3 sequences at this position contributes secondarily to the bypass by enhancing the sensitivity of the pA signal to the suppressive effects of promoter proximity.

Integrity signals

Registry

Crossref · 10.1002/j.1460-2075.1992.tb05196.x

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 40 · Cited by 64

Authors
Cherrington, J., & Ganem, D.
Affiliations
Howard Hughes Medical Institute (US)
Venue
The EMBO Journal
Published
1992-04-01
Volume
11
Issue
4
Pages
1513-1524
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W174335069
Cited by
64
References
40
Citations by year
2025: 2 · 2024: 1 · 2019: 2 · 2018: 1 · 2013: 1 · 2012: 2
FWCI
3.05
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords
HIV, polyadenylation, U3 region, upstream sequences
MeSH terms
Base Sequence, Genes, Regulator, HeLa Cells, HIV, Humans, Molecular Sequence Data, Poly A, Promoter Regions, Genetic, Proviruses, RNA, RNA Caps, RNA, Messenger, RNA, Viral, Transfection, Restriction Mapping, CD4 Antigens, Mutagenesis, Site-Directed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review